Clinical Trial: Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740330) titled 'Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery' on July 28.

Brief Summary: Tranexamic acid is commonly administered intravenously during cardiac surgery to reduce perioperative bleeding. Oral tranexamic acid may offer a simpler and less costly alternative, but its effectiveness in patients undergoing off-pump coronary artery bypass grafting has not been adequately established.

TRANSCAB is a randomized, double-blind, parallel-group, non-inferiority clinical trial comparing oral and intravenous tranexamic acid in adults undergoing elective off-pump coronary artery bypass grafting. Participants will ...